13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001892134-25-000006
Total Value
$2.50B
Positions
49
Other Managers
0
Confidential Omitted
No
Holdings (49)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MIRUM PHARMACEUTICALS INC | MIRM | 6,795,121 | $345.8M | 13.83% |
| 2 | VERONA PHARMA PLC | 925050106 | 3,383,950 | $320.1M | 12.80% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 16,607,074 | $300.8M | 12.03% |
| 4 | BRIDGEBIO PHARMA INC | BBIO | 3,800,457 | $164.1M | 6.56% |
| 5 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 9,874,511 | $138.4M | 5.54% |
| 6 | PHATHOM PHARMACEUTICALS INC | PHAT | 12,466,489 | $119.6M | 4.78% |
| 7 | KRYSTAL BIOTECH INC | KRYS | 688,460 | $94.6M | 3.78% |
| 8 | DISC MEDICINE INC | IRON | 1,654,834 | $87.6M | 3.50% |
| 9 | MBX BIOSCIENCES INC | MBX | 5,985,347 | $68.3M | 2.73% |
| 10 | TARSUS PHARMACEUTICALS INC | TARS | 1,397,527 | $56.6M | 2.26% |
| 11 | TREVI THERAPEUTICS INC | TRVI | 10,259,409 | $56.1M | 2.24% |
| 12 | MAZE THERAPEUTICS INC | MAZE | 4,567,275 | $56.0M | 2.24% |
| 13 | KALVISTA PHARMACEUTICALS INC | KALV | 4,887,867 | $55.3M | 2.21% |
| 14 | ZAI LAB LTD | ZLAB | 1,308,138 | $45.7M | 1.83% |
| 15 | AGIOS PHARMACEUTICALS INC | AGIO | 1,279,754 | $42.6M | 1.70% |
| 16 | REVOLUTION MEDICINES INC | RVMDW | 997,455 | $36.7M | 1.47% |
| 17 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 983,715 | $35.8M | 1.43% |
| 18 | AURA BIOSCIENCES INC | AURA | 5,100,000 | $31.9M | 1.28% |
| 19 | ERASCA INC | ERAS | 22,729,436 | $28.9M | 1.15% |
| 20 | ALKERMES PLC | ALKS | 1,000,647 | $28.6M | 1.14% |
| 21 | SAVARA INC | SVRA | 11,462,301 | $26.1M | 1.05% |
| 22 | MEREO BIOPHARMA GROUP PLC | MREO | 9,440,112 | $25.6M | 1.02% |
| 23 | ASCENDIS PHARMA A/S | ASND | 133,333 | $23.0M | 0.92% |
| 24 | EVOLUS INC | EOLS | 2,435,550 | $22.4M | 0.90% |
| 25 | HILLEVAX INC | 43157M102 | 10,617,062 | $21.1M | 0.84% |
| 26 | CG ONCOLOGY INC | CGON | 770,000 | $20.0M | 0.80% |
| 27 | AKERO THERAPEUTICS INC | 00973Y108 | 366,784 | $19.6M | 0.78% |
| 28 | CYTOKINETICS INC | CYTK | 554,731 | $18.3M | 0.73% |
| 29 | LEXEO THERAPEUTICS INC | LXEO | 4,424,725 | $17.8M | 0.71% |
| 30 | AVIDITY BIOSCIENCES INC | 05370A108 | 625,000 | $17.8M | 0.71% |
| 31 | JADE BIOSCIENCES INC | JBIO | 1,772,116 | $17.7M | 0.71% |
| 32 | PALVELLA THERAPEUTICS INC NE | PVLA | 722,400 | $16.3M | 0.65% |
| 33 | VAXCYTE INC | PCVX | 474,405 | $15.4M | 0.62% |
| 34 | TRAVERE THERAPEUTICS INC | TVTX | 1,002,092 | $14.8M | 0.59% |
| 35 | DYNE THERAPEUTICS INC | DYN | 1,505,984 | $14.3M | 0.57% |
| 36 | COGENT BIOSCIENCES INC | COGT | 1,734,601 | $12.5M | 0.50% |
| 37 | IMMUNOCORE HLDGS PLC | IMCR | 384,782 | $12.1M | 0.48% |
| 38 | ORIC PHARMACEUTICALS INC | ORIC | 1,065,334 | $10.8M | 0.43% |
| 39 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,623,324 | $10.5M | 0.42% |
| 40 | VALNEVA SE | VALN | 1,458,333 | $8.2M | 0.33% |
| 41 | CRESCENT BIOPHARMA INC. | CBIO | 453,685 | $7.3M | 0.29% |
| 42 | DESIGN THERAPEUTICS INC | DSGN | 1,953,547 | $6.6M | 0.26% |
| 43 | ORUKA THERAPEUTICS INC | ORKA | 583,327 | $6.5M | 0.26% |
| 44 | SILENCE THERAPEUTICS PLC | SLNCF | 970,130 | $5.6M | 0.23% |
| 45 | ALLOGENE THERAPEUTICS INC | ALLO | 3,868,750 | $4.4M | 0.17% |
| 46 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $4.0M | 0.16% |
| 47 | MACROGENICS INC | MGNX | 3,175,665 | $3.8M | 0.15% |
| 48 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,069,244 | $2.3M | 0.09% |
| 49 | ELEVATION ONCOLOGY INC | 28623U101 | 5,993,579 | $2.2M | 0.09% |